RecruitingNot applicableNCT07366099
Al18F-NOTA-LM3 PET/CT in Patients With TIO
Studying Oncogenic osteomalacia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking Union Medical College Hospital
- Intervention
- Diagnostic Test: Al18F-NOTA-LM3(drug)
- Enrollment
- 40 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07366099 on ClinicalTrials.govOther trials for Oncogenic osteomalacia
Additional recruiting or active studies for the same condition.